Targeting enzyme could block cancer spread to brain with fewer side effects

Article excerpt

A new study has identified a more precise and effective way to prevent cancer from spreading to the brain. The paper, published in the Proceedings of the National Academy of Sciences, details the development of novel drug candidates that target a key enzyme implicated in the spread of lung, breast, skin and other cancers to the brain. The work builds on a promising new therapeutic strategy first reported by the same group of researchers last year.